Skip to main content

Daniel Kelly Benjamin Jr.

Kiser-Arena Distinguished Professor
Pediatrics, Infectious Diseases
Duke Box 17969, Duke Clinical Research Institute, Durham, NC 27710
300 W Morgan St, Suite 800, Durham, NC 27701

Overview


Dr. Danny Benjamin is the Principal Investigator and Chair of the National Institute of Child Health and Human Development’s Pediatric Trials Network. The Network is responsible for designing and leading clinical trials of off-patent medicines in children of all ages across all therapeutic areas. The team has established, or is actively studying, the correct dosing and safety of more than 100 of the most commonly used medicines in children. These trials are conducted under an Investigational New Drug (IND) application with guidance from the Food and Drug Administration for labeling.

The Pediatric Trials Network has directly impacted the healthcare of over 90% of American children.

Signature programs of the Network include clinical trials in premature, term infants, breast feeding mothers, and obese children. Over the past 10 years, Danny’s group has enrolled more premature infants, at more sites, in more clinical trials of off-patent anti-infectives under an IND than all other academic medical centers, pharmaceutical companies, and government agencies in the world, combined.

Danny is recognized by the National Institutes of Health as a premiere mentor and educator. His research program serves as a platform to train students and early career investigators. Danny’s group has a clinical research summer program for high school, college graduate school, and medical students that recruits and mentors ~30 students each academic year.  He has been the primary or secondary mentor for 10 faculty who have received career development awards and who have then gone on to establish their own independent research programs; six of whom are now Distinguished Professors.

Danny's service to the community is expressed through his passion for coaching baseball. He has coached over 1,000 recreation league, travel league, and scholastic baseball games. He is the head coach for Smith Middle School Baseball, perennially southern conference champions. Danny and his wife own a charitable non-profit that provides athletic and fitness opportunities for disadvantaged and special-needs school-aged boys and girls.

Current Appointments & Affiliations


Kiser-Arena Distinguished Professor · 2014 - Present Pediatrics, Infectious Diseases, Pediatrics
Professor of Pediatrics · 2010 - Present Pediatrics, Infectious Diseases, Pediatrics
Deputy Director of Duke Clinical Research Institute · 2020 - Present Duke Clinical Research Institute, Institutes and Centers
Member in the Duke Clinical Research Institute · 2001 - Present Duke Clinical Research Institute, Institutes and Centers

In the News


Published September 16, 2022
No More Guessing on the Right Dosage for Children
Published September 16, 2022
No More Guessing on the Right Dosage for Children
Published March 10, 2022
Universal Masking in Schools is Shown to Reduce Spread of COVID-19

View All News

Recent Publications


Evaluation of electronic health record to HL7® FHIR® mappings in pediatric research studies.

Journal Article Int J Med Inform · April 1, 2026 BACKGROUND: eSource technologies that exchange patient data from electronic health records (EHR) to clinical study electronic data capture (EDC) systems can reduce data quality errors and decrease data collection time. However, the availability of site-spe ... Full text Link to item Cite

Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity.

Journal Article Clin Pharmacokinet · February 2026 BACKGROUND: Oxcarbazepine (OXZ) is an antiepileptic drug whose pharmacological effect is primarily mediated by its active metabolite, 10-monohydroxy derivative (MHD). OXZ is approved for use in adults and children older than 2 years with an age- and body w ... Full text Link to item Cite

Outcomes of Mothers and Infants Affected by COVID-19.

Journal Article Am J Perinatol · January 2026 The long-term effects of the novel coronavirus disease 2019 (COVID-19) infection during pregnancy are poorly characterized in mothers and their infants. The aim of this study was to assess the physical, mental, and emotional well-being of mothers and infan ... Full text Link to item Cite
View All Publications

Recent Grants


Best Pharmaceuticals for Children Act Pediatric Trials Network

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2032

PTN 3.0 Task Order #2_ BPCA Pediatric Drug Development Clinical Trial Infrastructure

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2030

View All Grants

Education, Training & Certifications


University of North Carolina, Chapel Hill · 2003 Ph.D.
University of North Carolina, Chapel Hill · 2001 M.P.H.
University of Virginia · 1995 M.D.